Evidence map›Paper›PMID 22298786›Full record

ArticleThe Journal of biological chemistry2012

Role of metalloproteases in vaccinia virus epitope processing for transporter associated with antigen processing (TAP)-independent human leukocyte antigen (HLA)-B7 class I antigen presentation.

Elena Lorente, Ruth García, Carmen Mir, Alejandro Barriga, François A Lemonnier, Manuel Ramos, Daniel López

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Clinical and immunological remarks about TAP deficiency.The Journal of biological chemistry · 2012
    Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Elena LorenteInstituto de Salud Carlos III, Centro Nacional de Microbiología, 28220 Majadahonda (Madrid), Spain and.
Ruth GarcíaInstituto de Salud Carlos III, Centro Nacional de Microbiología, 28220 Majadahonda (Madrid), Spain and.
Carmen MirInstituto de Salud Carlos III, Centro Nacional de Microbiología, 28220 Majadahonda (Madrid), Spain and.
Alejandro BarrigaInstituto de Salud Carlos III, Centro Nacional de Microbiología, 28220 Majadahonda (Madrid), Spain and.
François A LemonnierUnité d'Immunité Cellulaire Antivirale, Département d'Immunologie, Institut Pasteur, Paris Cedex 15, France.
Manuel RamosInstituto de Salud Carlos III, Centro Nacional de Microbiología, 28220 Majadahonda (Madrid), Spain and.
Daniel LópezInstituto de Salud Carlos III, Centro Nacional de Microbiología, 28220 Majadahonda (Madrid), Spain and. Electronic address: dlopez@isciii.es.
Centro Nacional de Microbiologia · ESInstituto de Salud Carlos III · ESInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transporter associated with antigen processing (TAP) translocates the viral proteolytic peptides generated by the proteasome and other proteases in the cytosol to the endoplasmic reticulum lumen. There, they complex with nascent human leukocyte antigen (HLA) class I molecules, which are subsequently recognized by the CD8(+) lymphocyte cellular response. However, individuals with nonfunctional TAP complexes or tumor or infected cells with blocked TAP molecules are able to present HLA class I ligands generated by TAP-independent processing pathways. Herein, using a TAP-independent polyclonal vaccinia virus-polyspecific CD8(+) T cell line, two conserved vaccinia-derived TAP-independent HLA-B*0702 epitopes were identified. The presentation of these epitopes in normal cells occurs via complex antigen-processing pathways involving the proteasome and/or different subsets of metalloproteinases (amino-, carboxy-, and endoproteases), which were blocked in infected cells with specific chemical inhibitors. These data support the hypothesis that the abundant cellular proteolytic systems contribute to the supply of peptides recognized by the antiviral cellular immune response, thereby facilitating immunosurveillance. These data may explain why TAP-deficient individuals live normal life spans without any increased susceptibility to viral infections.

Indexed as

Antigen PresentationAnimalsAntigens, LyCD8-Positive T-LymphocytesEpitopesHLA-B7 AntigenHumansMembrane ProteinsMetalloproteasesMiceMice, TransgenicProteasome Endopeptidase ComplexVacciniaVaccinia virusAntigens, LyEpitopesHLA-B7 AntigenLy6a protein, mouseMembrane ProteinsMetalloproteasesProteasome Endopeptidase Complex

Identifiers

PMID22298786
PMCPMC3323003
OpenAlexW2045080821

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.